0001209191-16-110591.txt : 20160325 0001209191-16-110591.hdr.sgml : 20160325 20160325152013 ACCESSION NUMBER: 0001209191-16-110591 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160323 FILED AS OF DATE: 20160325 DATE AS OF CHANGE: 20160325 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 161529602 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-03-23 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2016-03-23 4 M 0 5130 35.35 A 270414 D Common Stock 2016-03-23 4 S 0 3030 80.64 D 267384 D Common Stock 2016-03-23 4 S 0 900 81.48 D 266484 D Common Stock 2016-03-23 4 S 0 800 82.77 D 265684 D Common Stock 2016-03-23 4 S 0 200 83.33 D 265484 D Common Stock 2016-03-23 4 S 0 200 84.54 D 265284 D Common Stock 13286 I 401(k) Common Stock 122700 I Common Stock held in trust Stock Option (Right to Buy) 35.35 2016-03-23 4 M 0 5130 0.00 D 2016-07-19 Common Stock 5130 76960 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $80.64 (range $80.15 to $81.12). Open market sales reported on this line occurred at a weighted average price of $81.48 (range $81.22 to $82.02). Open market sales reported on this line occurred at a weighted average price of $82.77 (range $82.28 to $83.25). Open market sales reported on this line occurred at a weighted average price of $83.33 (range $83.29 to $83.37). Open market sales reported on this line occurred at a weighted average price of $84.54 (range $84.53 to $84.54). Fully vested. Omar White, Attorney-In-Fact 2016-03-25